Conditions: Rhinitis, Allergic, Seasonal
Keywords: Seasonal allergic rhinitis, hayfever
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 32
Healthy volunteers: no

Brief summary:
This current study is planned as a dedicated pharmacodynamic (effect of drug on the body) study to investigate the dose response in rhinitic subjects at doses where GSK256066 has been proven to work (200mcg) or expected to (50mcg) work. This study also aims to investigate the lower end of the predicted therapeutic range.

Detailed description:

Arms:

Interventions: intervention 1: GSK256066
Intervention descriptions: intervention 1: None

Protocol document: